Selective Antibodies Limited

Selective Antibodies Limited is a company in Newcastle upon Tyne, United Kingdom that has taken part in 2 EU-funded projects since 2010, receiving €1.9M in EU funding.

EU funding received€1.9M
EU projects2
As coordinator0
Running now0
First EU project2010
Latest project2010
CountryUnited Kingdom
EU registration (PIC)995416038
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Selective Antibodies Limited's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€1.9M · 2 projects

Projects

2 EU-funded projects, newest first. Each links to the official record.

  • SALIANTPartner

    Selective Antibodies Limited Immuno Assay Novel Technology

    FP7 (2007 to 2013) · 2010–2013 · Project on CORDIS ↗

    €1.2Mtheir share
  • NAMDIATREAMPartner

    NANOTECHNOLOGICAL TOOLKITS FOR MULTI-MODAL DISEASE DIAGNOSTICS AND TREATMENT MONITORING

    FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

    €677ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • diagnostic imaging
  • lab on a chip
  • nanocrystals
  • nanomedicine
  • oncology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime